{
    "2020-06-28": [
        [
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)合作研发的新型冠状病毒mRNA疫苗获得药物临床试验批件",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "mRNA疫苗",
                        "临床试验",
                        "新冠病毒"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业报告：新冠疫苗研发步入关键阶段 - 现有数据怎么看 III期临床如何开展？",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "III期临床",
                        "研发进展"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "时代医药周报 | 上半年医药行业涨幅居首，多方新冠肺炎疫苗研发齐突破",
                "features": {
                    "keywords": [
                        "医药行业",
                        "涨幅",
                        "新冠疫苗",
                        "研发突破"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[天风医药 | 周报】国内或将进一步加大检测需求，全球疫情仍未见拐点",
                "features": {
                    "keywords": [
                        "检测需求",
                        "全球疫情",
                        "拐点"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "GSK重组带状疱疹疫苗欣安立适登陆中国 国内多家企业正在追赶",
                "features": {
                    "keywords": [
                        "GSK",
                        "重组带状疱疹疫苗",
                        "欣安立适",
                        "国内企业"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：中国首个mRNA新型冠状病毒疫苗获批进入临床试验阶段",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "mRNA疫苗",
                        "临床试验",
                        "新冠病毒"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}